Stockport NHS Foundation Trust
Please find below information on therapeutic apheresis service providers for Stockport NHS Foundation Trust:
Haematology - If you require Therapeutic Apheresis for haematological conditions please contact the organisations / departments as listed below:
Thrombotic Thrombocytopenic Purpura (TTP) – For patients with suspected TTP / Microangiopathic Haemolytic Anaemia (MAHA) please contact Haematology at the Royal Liverpool University Hospital for advice and access to therapeutic apheresis if required. Contact and referral information can be found here.
Red Cell Exchange – For patients with sickle cell disease please contact Haematology at the Manchester Royal Infirmary for advice (red cell team during working hours, general haematology on call out of hours)
Hyperviscosity – contact your tertiary provider for haemato-oncology for advice and access to therapeutic apheresis if required
Leucodepletion - contact your tertiary provider for haemato-oncology for advice and access to therapeutic apheresis if required
Renal conditions / vasculitides – For patients who may require therapeutic apheresis please contact your tertiary renal care provider at Mancehster Royal Infirmary for advice and access to treatment
Neurological conditions – For patients who may require therapeutic apheresis please contact your tertiary neurology service provider at Salford Royal for advice and access to treatment
Extracorporeal Photopheresis - NHS Blood and Transplant.
Hyperlipidaemia - To discuss treatment for Hyperlipidaemia please contact Dr Handrean Soran at Manchester Royal Infirmary.
For advice regarding access to therapeutic apheresis services for other urgent clinical conditions, please contact the NHS Blood and Transplant Patient Clinical Team on call Consultant. Contact details are available here.
If you require access to therapeutic apheresis services from NHS Blood & Transplant but do not currently hold a service level agreement, please refer to the referral information on the website relating to the use of “One Off Treatment Request” forms.